Clinical Trial

CLIME-CJD: A Multimodal Study

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Creutzfeldt-Jakob disease (CJD) is a rare and rapidly progressive neurological disorder. This study aims to describe and summarize the key features of CJD by looking back at medical records of patients who were diagnosed with CJD at our hospital. The researchers will collect information from routine clinical evaluations, including patients' symptoms, blood tests, cerebrospinal fluid analysis, brain imaging (such as MRI and PET), and electroencephalography (EEG). By analyzing these data together, the study hopes to provide a clearer picture of how CJD presents in routine clinical practice. This may help doctors recognize the disease more quickly in the future. No new tests or treatments will be given to patients. All data are collected from existing medical records.
Trial Details
NCT Number NCT07589283
Lead Sponsor First Affiliated Hospital of Fujian Medical University
Conditions Creutzfeldt-Jakob Disease (CJD) | Prion Disease
Enrollment 150 participants
Start Date 2022-01-01
Primary Completion 2031-12 (estimated)
Study Completion 2031-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-15